Dean Spurden

1.3k total citations
33 papers, 1.0k citations indexed

About

Dean Spurden is a scholar working on Hematology, Molecular Biology and Rheumatology. According to data from OpenAlex, Dean Spurden has authored 33 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 9 papers in Molecular Biology and 8 papers in Rheumatology. Recurrent topics in Dean Spurden's work include Nicotinic Acetylcholine Receptors Study (9 papers), Hemophilia Treatment and Research (7 papers) and Rheumatoid Arthritis Research and Therapies (7 papers). Dean Spurden is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (9 papers), Hemophilia Treatment and Research (7 papers) and Rheumatoid Arthritis Research and Therapies (7 papers). Dean Spurden collaborates with scholars based in United Kingdom, United States and Italy. Dean Spurden's co-authors include J.A. Court, Elaine Perry, Stephen Lloyd, Martin Griffiths, Margaret A. Piggott, Robert Perry, Carmen Martín-Ruiz, Ian G. McKeith, Clive Ballard and Nigel J. Cairns and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Neurology.

In The Last Decade

Dean Spurden

31 papers receiving 1.0k citations

Peers

Dean Spurden
M. Frigo Italy
Brice Ongali Canada
Rita Cittadella Italy
Lars Lannfelt Sweden
Zbigniew Stelmasiak Poland
Martin Koller United States
S. M. Podos United States
Monique Gastineau France
Roberto Colombo Italy
Sooyeon Jo United States
M. Frigo Italy
Dean Spurden
Citations per year, relative to Dean Spurden Dean Spurden (= 1×) peers M. Frigo

Countries citing papers authored by Dean Spurden

Since Specialization
Citations

This map shows the geographic impact of Dean Spurden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dean Spurden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dean Spurden more than expected).

Fields of papers citing papers by Dean Spurden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dean Spurden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dean Spurden. The network helps show where Dean Spurden may publish in the future.

Co-authorship network of co-authors of Dean Spurden

This figure shows the co-authorship network connecting the top 25 collaborators of Dean Spurden. A scholar is included among the top collaborators of Dean Spurden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dean Spurden. Dean Spurden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harbeck, Nadia, Dean Spurden, Lin Zhan, et al.. (2021). CDK4/6 Inhibitors in HR+/HER2- Advanced/metastatic Breast Cancer: A Systematic Literature Review of Real-World Evidence Studies. Future Oncology. 17(16). 2107–2122. 51 indexed citations
2.
Criscitiello, Carmen, Dean Spurden, James Piercy, et al.. (2021). Health-Related Quality of Life Among Patients With HR+/HER2– Early Breast Cancer. Clinical Therapeutics. 43(7). 1228–1244.e4. 17 indexed citations
3.
Criscitiello, Carmen, Dean Spurden, A. Rider, et al.. (2020). 82P A multinational study of real-world treatment patterns among patients with early stage HR+/HER2- breast cancer (BC). Annals of Oncology. 31. S42–S43. 2 indexed citations
4.
Chhabra, Amit, Dean Spurden, Patrick F. Fogarty, et al.. (2020). Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and B. Blood Coagulation & Fibrinolysis. 31(3). 186–192. 25 indexed citations
5.
Taylor, Peter C., Rieke Alten, Juan J. Gómez‐Reino, et al.. (2018). Factors influencing use of biologic therapy and adoption of treat-to-target recommendations in current European rheumatology practice. Patient Preference and Adherence. Volume 12. 2007–2014. 6 indexed citations
6.
7.
Tolley, Chloe, et al.. (2016). Further Validation of the Haemopref in a Real-World Setting. Value in Health. 19(7). A383–A384. 1 indexed citations
8.
9.
Schulz, Martin, Ana Gordo, Chloe Tolley, et al.. (2016). Evaluating Patient Preference for Haemophilia a Treatment. Blood. 128(22). 4973–4973. 1 indexed citations
10.
Spurden, Dean, et al.. (2015). The Burden of Rheumatoid Arthritis in Russia. Value in Health. 18(7). A651–A651. 1 indexed citations
11.
Mitchell, Stephen, et al.. (2014). Systematic review, network meta-analysis and economic evaluation of biological therapy for the management of active psoriatic arthritis. BMC Musculoskeletal Disorders. 15(1). 26–26. 43 indexed citations
12.
Mills, Edward J., Ping Wu, Dean Spurden, Jon O. Ebbert, & Kumanan Wilson. (2009). Efficacy of pharmacotherapies for short-term smoking abstinance: A systematic review and meta-analysis. Harm Reduction Journal. 6(1). 25–25. 46 indexed citations
13.
Court, J.A., Carmen Martín-Ruiz, Margaret A. Piggott, et al.. (2001). Nicotinic receptor abnormalities in Alzheimer’s disease. Biological Psychiatry. 49(3). 175–184. 195 indexed citations
14.
Court, J.A., Dean Spurden, Stephen Lloyd, et al.. (1999). Neuronal Nicotinic Receptors in Dementia with Lewy Bodies and Schizophrenia. Journal of Neurochemistry. 73(4). 1590–1597. 209 indexed citations
15.
Fornasari, Diego, Martin Griffiths, Dean Spurden, et al.. (1998). Expression of the α3 nicotinic receptor subunit mRNA in aging and Alzheimer's disease. Molecular Brain Research. 63(1). 72–78. 43 indexed citations
16.
Perry, Elaine, J.A. Court, Rose E. Goodchild, et al.. (1998). Clinical neurochemistry: developments in dementia research based on brain bank material. Journal of Neural Transmission. 105(8-9). 915–933. 60 indexed citations
17.
Spurden, Dean, J.A. Court, Stephen Lloyd, et al.. (1997). Nicotinic receptor distribution in the human thalamus: autoradiographical localization of [3H]nicotine and [125I]α-bungarotoxin binding. Journal of Chemical Neuroanatomy. 13(2). 105–113. 61 indexed citations
18.
Perry, Elaine K., J.A. Court, Stephen Lloyd, et al.. (1996). β‐Amyloidosis in Normal Aging and Transmitter Signaling in Human Temporal Lobea. Annals of the New York Academy of Sciences. 777(1). 388–392. 20 indexed citations
19.
Johnson, Martin H., R.H. Perry, Margaret A. Piggott, et al.. (1996). Glutamate receptor binding in the human hippocampus and adjacent cortex during development and aging. Neurobiology of Aging. 17(4). 639–651. 20 indexed citations
20.
Court, J.A., Elaine K. Perry, Dean Spurden, et al.. (1995). The role of the cholinergic system in the development of the human cerebellum. Developmental Brain Research. 90(1-2). 159–167. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Frigo Breakdown of academic impact, for papers by Brice Ongali Breakdown of academic impact, for papers by Rita Cittadella Breakdown of academic impact, for papers by Lars Lannfelt Breakdown of academic impact, for papers by Zbigniew Stelmasiak Breakdown of academic impact, for papers by Martin Koller Breakdown of academic impact, for papers by S. M. Podos Breakdown of academic impact, for papers by Monique Gastineau Breakdown of academic impact, for papers by Roberto Colombo Breakdown of academic impact, for papers by Sooyeon Jo
Rankless by CCL
2026